IL2RA and autoimmune disease: Anti-CD25, anti-IL-2Rα, anti-CD52, anti-CD20, anti-IL-6R, and anti-TNF antibodies have been approved for clinical use against autoimmune diseases, such as multiple sclerosis, RA, and Chron’s disease [72].